000 | 01810 a2200517 4500 | ||
---|---|---|---|
005 | 20250513142445.0 | ||
264 | 0 | _c19980608 | |
008 | 199806s 0 0 eng d | ||
022 | _a0021-9738 | ||
024 | 7 |
_a10.1172/JCI1268 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAsai, O | |
245 | 0 | 0 |
_aSuppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. _h[electronic resource] |
260 |
_bThe Journal of clinical investigation _cMay 1998 |
||
300 |
_a1835-42 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAdenocarcinoma _ximmunology |
650 | 0 | 4 | _aAdoptive Transfer |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBone Marrow Transplantation _ximmunology |
650 | 0 | 4 |
_aColonic Neoplasms _ximmunology |
650 | 0 | 4 |
_aGraft vs Host Disease _xmortality |
650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
650 | 0 | 4 |
_aIntestines _ximmunology |
650 | 0 | 4 |
_aKiller Cells, Natural _xdrug effects |
650 | 0 | 4 |
_aLiver _ximmunology |
650 | 0 | 4 |
_aLung Neoplasms _xsecondary |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 | _aMice, Inbred C3H |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, SCID |
650 | 0 | 4 |
_aSkin _ximmunology |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTransforming Growth Factor beta _ximmunology |
650 | 0 | 4 | _aTransplantation, Homologous |
700 | 1 | _aLongo, D L | |
700 | 1 | _aTian, Z G | |
700 | 1 | _aHornung, R L | |
700 | 1 | _aTaub, D D | |
700 | 1 | _aRuscetti, F W | |
700 | 1 | _aMurphy, W J | |
773 | 0 |
_tThe Journal of clinical investigation _gvol. 101 _gno. 9 _gp. 1835-42 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI1268 _zAvailable from publisher's website |
999 |
_c9543657 _d9543657 |